Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond Yan-Kit Kwong, M.D.

Co-Author

This page shows the publications co-authored by Raymond Kwong and Michael Jerosch-Herold.
Connection Strength

10.217
  1. The Authors Reply. JACC Cardiovasc Imaging. 2019 12; 12(12):2587-2588.
    View in: PubMed
    Score: 0.871
  2. Cardiac T(1) imaging. Top Magn Reson Imaging. 2014 Feb; 23(1):3-11.
    View in: PubMed
    Score: 0.582
  3. CMR and amyloid cardiomyopathy: are we getting closer to the biology? JACC Cardiovasc Imaging. 2014 Feb; 7(2):166-8.
    View in: PubMed
    Score: 0.582
  4. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease. Curr Opin Cardiol. 2008 Nov; 23(6):599-606.
    View in: PubMed
    Score: 0.404
  5. Magnetic resonance imaging in the assessment of ventricular remodeling and viability. Curr Heart Fail Rep. 2008 Mar; 5(1):5-10.
    View in: PubMed
    Score: 0.386
  6. Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes. JACC Cardiovasc Imaging. 2020 07; 13(7):1505-1517.
    View in: PubMed
    Score: 0.225
  7. Insulin Resistance Modifies the Effects of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction (from the OMEGA-REMODEL Randomized Clinical Trial). Am J Cardiol. 2020 03 01; 125(5):678-684.
    View in: PubMed
    Score: 0.218
  8. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial. PLoS One. 2019; 14(9):e0222061.
    View in: PubMed
    Score: 0.215
  9. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis. J Cardiovasc Magn Reson. 2019 02 28; 21(1):14.
    View in: PubMed
    Score: 0.207
  10. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Int J Cardiovasc Imaging. 2019 Jun; 35(6):1067-1078.
    View in: PubMed
    Score: 0.206
  11. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2019 08; 12(8 Pt 2):1659-1669.
    View in: PubMed
    Score: 0.203
  12. Omega-3 Fatty Acids Effect on Post-Myocardial Infarction ST2 Levels for Heart Failure and Myocardial Fibrosis. J Am Coll Cardiol. 2018 08 21; 72(8):953-955.
    View in: PubMed
    Score: 0.199
  13. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017 Oct 17; 70(16):1964-1976.
    View in: PubMed
    Score: 0.188
  14. Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy. PLoS One. 2016; 11(11):e0164914.
    View in: PubMed
    Score: 0.176
  15. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation. 2016 Aug 02; 134(5):378-91.
    View in: PubMed
    Score: 0.173
  16. Stress Perfusion Cardiac Magnetic Resonance Imaging Effectively Risk Stratifies Diabetic Patients With Suspected Myocardial Ischemia. Circ Cardiovasc Imaging. 2016 Apr; 9(4):e004136.
    View in: PubMed
    Score: 0.169
  17. Late gadolinium enhancement among survivors of sudden cardiac arrest. JACC Cardiovasc Imaging. 2015 Apr; 8(4):414-423.
    View in: PubMed
    Score: 0.157
  18. Technical advances and clinical applications of quantitative myocardial blood flow imaging with cardiac MRI. Prog Cardiovasc Dis. 2015 May-Jun; 57(6):615-22.
    View in: PubMed
    Score: 0.157
  19. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Circ Cardiovasc Imaging. 2014 Nov; 7(6):887-894.
    View in: PubMed
    Score: 0.152
  20. Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery disease. Am J Cardiol. 2014 Oct 15; 114(8):1198-203.
    View in: PubMed
    Score: 0.150
  21. Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Prev Cardiol. 2015 Nov; 22(11):1408-18.
    View in: PubMed
    Score: 0.150
  22. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc. 2014 Jun 25; 3(3):e000790.
    View in: PubMed
    Score: 0.149
  23. Left atrial passive emptying function determined by cardiac magnetic resonance predicts atrial fibrillation recurrence after pulmonary vein isolation. Circ Cardiovasc Imaging. 2014 Jul; 7(4):586-92.
    View in: PubMed
    Score: 0.149
  24. Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients. JACC Cardiovasc Imaging. 2014 May; 7(5):462-72.
    View in: PubMed
    Score: 0.147
  25. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014 Jan; 7(1):1-11.
    View in: PubMed
    Score: 0.144
  26. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2013 Nov 25; 2(6):e000421.
    View in: PubMed
    Score: 0.144
  27. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . J Am Coll Cardiol. 2013 Dec 10; 62(23):2205-14.
    View in: PubMed
    Score: 0.141
  28. Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc. 2013 Aug 20; 2(4):e000279.
    View in: PubMed
    Score: 0.141
  29. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013 Sep; 6(9):944-54.
    View in: PubMed
    Score: 0.141
  30. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation. 2013 Sep 10; 128(11):1225-33.
    View in: PubMed
    Score: 0.140
  31. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation. 2013 Aug 06; 128(6):605-14.
    View in: PubMed
    Score: 0.140
  32. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging. 2013 Jun; 6(6):672-83.
    View in: PubMed
    Score: 0.138
  33. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013 Apr 23; 61(16):1698-706.
    View in: PubMed
    Score: 0.138
  34. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013 May 01; 6(3):415-22.
    View in: PubMed
    Score: 0.137
  35. MR myocardial perfusion imaging. Radiology. 2013 Mar; 266(3):701-15.
    View in: PubMed
    Score: 0.136
  36. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013 Mar 01; 111(5):717-22.
    View in: PubMed
    Score: 0.134
  37. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging. 2013 Jan 01; 6(1):134-41.
    View in: PubMed
    Score: 0.134
  38. Insights into left ventricular remodeling through noninvasive measures of myocardial matrix expansion with cardiovascular magnetic resonance. Circulation. 2012 Sep 04; 126(10):1179-81.
    View in: PubMed
    Score: 0.132
  39. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging. 2012 Sep; 5(9):897-907.
    View in: PubMed
    Score: 0.132
  40. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol. 2012 Dec 01; 110(11):1679-86.
    View in: PubMed
    Score: 0.132
  41. Imaging for planning of cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2012 Jan; 5(1):93-110.
    View in: PubMed
    Score: 0.126
  42. Assessment of myocardial ischemia with cardiovascular magnetic resonance. Prog Cardiovasc Dis. 2011 Nov-Dec; 54(3):191-203.
    View in: PubMed
    Score: 0.124
  43. Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension. J Cardiovasc Magn Reson. 2011 Aug 15; 13:42.
    View in: PubMed
    Score: 0.123
  44. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging. 2011 Aug; 4(8):850-61.
    View in: PubMed
    Score: 0.122
  45. Images in cardiovascular medicine. Löffler endocarditis presenting with recurrent polymorphic ventricular tachycardia diagnosed by cardiac magnetic resonance imaging. Circulation. 2010 Jul 06; 122(1):96-9.
    View in: PubMed
    Score: 0.114
  46. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation. 2009 Oct 06; 120(14):1390-400.
    View in: PubMed
    Score: 0.107
  47. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy. Circulation. 2021 Aug 24; 144(8):589-599.
    View in: PubMed
    Score: 0.061
  48. Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR. JACC Clin Electrophysiol. 2021 Jun 23.
    View in: PubMed
    Score: 0.061
  49. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis. J Am Coll Cardiol. 2021 03 30; 77(12):1503-1516.
    View in: PubMed
    Score: 0.060
  50. Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study. Int J Cardiol. 2021 05 01; 330:251-258.
    View in: PubMed
    Score: 0.059
  51. Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis. Circulation. 2021 Feb 09; 143(6):606-608.
    View in: PubMed
    Score: 0.058
  52. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
    View in: PubMed
    Score: 0.056
  53. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. J Am Coll Cardiol. 2019 11 12; 74(19):2333-2345.
    View in: PubMed
    Score: 0.054
  54. Correction to: Imaging the myocardial ischemic cascade. Int J Cardiovasc Imaging. 2018 09; 34(9):1503.
    View in: PubMed
    Score: 0.050
  55. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173.
    View in: PubMed
    Score: 0.050
  56. Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction. EBioMedicine. 2018 Jun; 32:172-181.
    View in: PubMed
    Score: 0.049
  57. Imaging the myocardial ischemic cascade. Int J Cardiovasc Imaging. 2018 Aug; 34(8):1249-1263.
    View in: PubMed
    Score: 0.048
  58. Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus. Metab Syndr Relat Disord. 2017 08; 15(6):269-275.
    View in: PubMed
    Score: 0.046
  59. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016 Dec; 9(12).
    View in: PubMed
    Score: 0.044
  60. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc. 2016 Sep 26; 5(9).
    View in: PubMed
    Score: 0.044
  61. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy. Circ Heart Fail. 2016 09; 9(9).
    View in: PubMed
    Score: 0.043
  62. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. Am Heart J. 2015 Aug; 170(2):223-30.
    View in: PubMed
    Score: 0.040
  63. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014 Dec; 7(12):1221-35.
    View in: PubMed
    Score: 0.038
  64. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Circ Cardiovasc Imaging. 2014 Nov; 7(6):920-9.
    View in: PubMed
    Score: 0.038
  65. T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol. 2014 Dec; 30(12):1668-75.
    View in: PubMed
    Score: 0.038
  66. Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes. 2015 Jan; 64(1):236-42.
    View in: PubMed
    Score: 0.038
  67. A 1.5T MRI-conditional 12-lead electrocardiogram for MRI and intra-MR intervention. Magn Reson Med. 2014 Mar; 71(3):1336-47.
    View in: PubMed
    Score: 0.037
  68. Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function. Am Heart J. 2014 Apr; 167(4):620-6.
    View in: PubMed
    Score: 0.036
  69. Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. Am J Cardiol. 2013 Jul 01; 112(1):73-8.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.